Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.

PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are required for current and future products. 16% of the top 100 pharmaceutical drugs ...

Along with PCI's own robust infrastructure expansions, acquisition furthers CDMO's recent growth in sterile fill-finish, advanced drug delivery ...

The acquisition also adds high potent vial filling with lyophilization, making PCI one of very few US-based CDMOs capable of producing the emerging oncology modality of antibody-drug conjugates ...

has established centers of excellence in drug development, lyophilization, preservative-free multidose technologies, and flexible stick-pack and sachet production. “There is a gap in the market ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

The acquisition also adds high potent vial filling with lyophilization, making PCI one of very few US-based CDMOs capable of producing the emerging oncology modality of antibody-drug conjugates (ADCs) ...